← FDA DRUG APPROVALS

FDA NDA · NDA020120

ALLERNAZE

Sponsor: LUPIN ATLANTIS

APPLICATION
NDA020120
TYPE
NDA
ORIGINAL APPROVAL
2000-02-04
LATEST ACTION
2009-01-07
ROUTE
NASAL
DOSAGE FORM
SPRAY, METERED
MARKETING STATUS
Discontinued

Products

ALLERNAZEDiscontinued
TRIAMCINOLONE ACETONIDE 0.05MG/SPRAY · SPRAY, METERED · NASAL

Approval history

2009-01-07Manufacturing (CMC) · Supplement 2 — Label ↗AP
2001-03-27Manufacturing (CMC) · Supplement 1 · standardAP
2000-02-04Type 3 - New Dosage Form · Original · standard — Label ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →